W. L. Gore & Associates Inc:企業の製品パイプライン分析

◆英語タイトル:W. L. Gore & Associates Inc - Product Pipeline Analysis, 2020 Update
◆商品コード:GDME2057PD
◆発行会社(調査会社):GlobalData
◆発行日:2021年1月
◆ページ数:43
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD1,500 ⇒換算¥171,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD2,250 ⇒換算¥256,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
W. L. Gore & Associates Inc (Gore) is a materials science company serving diverse industries. Its product portfolio includes consumer products, cables, electronic components, fabrics, fibers, medical, pharmaceutical, sealing and vents. The company develops products for medical implants; fabric laminates; and cable, filtration, membrane, venting, fiber technologies, and sealant for diverse industries through its proprietary technologies with the polymer polytetrafluoroethylene (PTFE). Gore caters to aerospace, automotive, chemical processing, computer, telecommunications, electronics, energy, environmental, industrial, manufacturing, military, and pharmaceutical, biotechnology, and textile markets. The company has manufacturing facilities in the US, China, Germany, the UK, and Japan. Gore is headquartered in Newark, Delaware, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company W. L. Gore & Associates Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
W. L. Gore & Associates Inc Company Overview
W. L. Gore & Associates Inc Company Snapshot
W. L. Gore & Associates Inc Pipeline Products and Ongoing Clinical Trials Overview
W. L. Gore & Associates Inc – Pipeline Analysis Overview
Business Description
W. L. Gore & Associates Inc – Key Facts
W. L. Gore & Associates Inc – Major Products and Services
W. L. Gore & Associates Inc Pipeline Products by Development Stage
W. L. Gore & Associates Inc Ongoing Clinical Trials by Trial Status
W. L. Gore & Associates Inc Pipeline Products Overview
BioTREK
BioTREK Product Overview
GORE Ascending Stent Graft
GORE Ascending Stent Graft Product Overview
GORE Ascending Stent Graft Clinical Trial
GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis
GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis Product Overview
GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis Clinical Trial
GORE PV1 Device
GORE PV1 Device Product Overview
GORE TAG Thoracic Branch Endoprosthesis
GORE TAG Thoracic Branch Endoprosthesis Product Overview
GORE TAG Thoracic Branch Endoprosthesis Clinical Trial
Transcatheter Mitral Chordal Repair Device
Transcatheter Mitral Chordal Repair Device Product Overview
W. L. Gore & Associates Inc – Key Competitors
W. L. Gore & Associates Inc – Key Employees
W. L. Gore & Associates Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
W. L. Gore & Associates Inc, Recent Developments
May 13, 2020: Gore PharmBIO introduces 9.0 mL Protein Capture Device to improve throughput and productivity in bioprocessing process development
Nov 12, 2019: W. L. Gore & Associates to reveal new gender insights from real-world aortic data At 2019 VEITHsymposium
Oct 22, 2019: Gore and SCHOTT to showcase commercial Option for Packaging and Delivery of Silicone-Sensitive Biologics
Oct 02, 2019: CE Mark supported by data from the Gore ASSURED Clinical Study, demonstrating 100 percent closure success
Jul 29, 2019: First Patient Receives Surgery in UNC-Led International Pivotal Trial for Repair of Thoracoabdominal and Pararenal Aortic Aneurysms
Jul 18, 2019: First patient enrolled in GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis pivotal study
Jul 17, 2019: GORE ENFORM Biomaterial earns innovative technology designation from Vizient
Jul 10, 2019: First U.S. patient receives GORE TAG Conformable Thoracic Stent Graft with ACTIVE CONTROL
Jun 04, 2019: GORE CARDIOFORM ASD Occluder receives FDA approval for the Treatment of Atrial Septal Defects
May 17, 2019: FDA approves Gore Tag Conformable Thoracic Stent Graft
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
W. L. Gore & Associates Inc Pipeline Products and Ongoing Clinical Trials Overview
W. L. Gore & Associates Inc Pipeline Products by Equipment Type
W. L. Gore & Associates Inc Pipeline Products by Indication
W. L. Gore & Associates Inc Ongoing Clinical Trials by Trial Status
W. L. Gore & Associates Inc, Key Facts
W. L. Gore & Associates Inc, Major Products and Services
W. L. Gore & Associates Inc Number of Pipeline Products by Development Stage
W. L. Gore & Associates Inc Pipeline Products Summary by Development Stage
W. L. Gore & Associates Inc Ongoing Clinical Trials by Trial Status
W. L. Gore & Associates Inc Ongoing Clinical Trials Summary
BioTREK - Product Status
BioTREK - Product Description
GORE Ascending Stent Graft - Product Status
GORE Ascending Stent Graft - Product Description
GORE Ascending Stent Graft - Early Feasibility Study to Evaluate the Use of GORE Endovascular Stent Graft in Treatment of Subjects with Type A Dissections of the Ascending Aorta
GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis - Product Status
GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis - Product Description
GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis - Early Feasibility Assessment of the GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis in the Treatment of Type IV Thoracoabdominal Aortic Aneurysms Involving the Visceral Branch Vessels
GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis - Evaluation of the GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis in the Treatment of Thoracoabdominal and Pararenal Aortic Aneurysms
GORE PV1 Device - Product Status
GORE PV1 Device - Product Description
GORE TAG Thoracic Branch Endoprosthesis - Product Status
GORE TAG Thoracic Branch Endoprosthesis - Product Description
GORE TAG Thoracic Branch Endoprosthesis - Early Feasibility Study to Evaluate the Use of GORE Endovascular Stent Graft in Treatment of Subjects with Type A Dissections of the Ascending Aorta
GORE TAG Thoracic Branch Endoprosthesis - Evaluation of the GORE TAG Thoracic Branch Endoprosthesis (Branched TAG Device) in the Treatment of Aortic Arch Aneurysms
GORE TAG Thoracic Branch Endoprosthesis - Evaluation of the GORE TAG Thoracic Branch Endoprosthesis (TBE Device) in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta
GORE TAG Thoracic Branch Endoprosthesis - Evaluation of the Gore Tag Thoracic Branch Endoprosthesis (TBE Device) in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta
GORE TAG Thoracic Branch Endoprosthesis - Evaluation of the GORE TAG Thoracic Branch Endoprosthesis in the Treatment of Proximal Descending Thoracic Aortic Aneurysms
GORE TAG Thoracic Branch Endoprosthesis - Global Registry for Endovascular Aortic Treatment - Outcomes Evaluation: GREAT
Transcatheter Mitral Chordal Repair Device - Product Status
Transcatheter Mitral Chordal Repair Device - Product Description
W. L. Gore & Associates Inc, Key Employees
W. L. Gore & Associates Inc, Other Locations
W. L. Gore & Associates Inc, Subsidiaries
Glossary

★海外企業調査レポート[W. L. Gore & Associates Inc:企業の製品パイプライン分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Fuji Pharma Co Ltd (4554):企業の財務・戦略的SWOT分析
    Summary Fuji Pharma Co Ltd (Fuji Pharma) develops, manufactures, and commercializes pharmaceutical products. The company specializes in offering injection agents, drugs for external use, internal drugs, and diagnostic products among others. It also provides medical care products for women, acute med …
  • Valeant Pharmaceuticals International, Inc.:企業の戦略・SWOT・財務情報
    Valeant Pharmaceuticals International, Inc. - Strategy, SWOT and Corporate Finance Report Summary Valeant Pharmaceuticals International, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation …
  • Qc Holdings Inc:企業の戦略・SWOT・財務分析
    Qc Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary Qc Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • China Gas Holdings Ltd (384):石油・ガス:M&Aディール及び事業提携情報
    Summary China Gas Holdings Ltd (CGHL) is a gas operator and service provider. The company offers piped natural gas, compressed natural gas, liquid petroleum gas and liquefied natural gas. Its activities include construction and operation of gas stations, gas pipeline infrastructure facilities, gas t …
  • Grasim Industries Ltd (GRASIM):企業の財務・戦略的SWOT分析
    Grasim Industries Ltd (GRASIM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Sejal Glass Limited (SEZAL):企業の財務・戦略的SWOT分析
    Sejal Glass Limited (SEZAL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Huesker Synthetic GmbH:企業の戦略・SWOT・財務情報
    Huesker Synthetic GmbH - Strategy, SWOT and Corporate Finance Report Summary Huesker Synthetic GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Esperion Therapeutics Inc (ESPR):企業の財務・戦略的SWOT分析
    Summary Esperion Therapeutics Inc (Esperion), a subsidiary of Pfizer Inc is a pharmaceutical company that develops and commercializes once-daily, oral and low-density lipoprotein cholesterol lowering therapies. The company develops oral therapies to treat patients with elevated low-density lipoprote …
  • Mondelez International Inc (MDLZ):企業の財務・戦略的SWOT分析
    Mondelez International Inc (MDLZ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • China Petrochemical Corp:石油・ガス:M&Aディール及び事業提携情報
    Summary China Petrochemical Corp (Sinopec Corp) is a petroleum and petrochemical company. The company is engaged in the engaged in the exploration and production, pipeline transportation, and sale of petroleum and natural gas. It is also involved in the production, sale, storage and transportation o …
  • Altana Ag:企業の戦略・SWOT・財務分析
    Altana Ag - Strategy, SWOT and Corporate Finance Report Summary Altana Ag - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Advantest Corporation:企業の戦略・SWOT・財務分析
    Advantest Corporation - Strategy, SWOT and Corporate Finance Report Summary Advantest Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Thermax Ltd (THERMAX):企業の財務・戦略的SWOT分析
    Thermax Ltd (THERMAX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • PNE Wind AG (PNE3)-エネルギー分野:企業M&A・提携分析
    Summary PNE Wind AG (PNE) is a renewable energy company. It has a presence in the entire value added chain in the wind energy sector. The company develops, manages projects, realizes, finances, and operates wind-farm projects. PNE also offers commercial and technical operating management services fo …
  • Cyteir Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Cyteir Therapeutics Inc (Cyteir Therapeutics) discovers, develops and commercializes synthetic lethal therapeutics for the treatment of cancer and autoimmune disease. It specializes in the development of small molecules that targets RAD51 to induce synthetic lethality in diseases with a gain …
  • Omaxe Ltd:企業の戦略・SWOT・財務情報
    Omaxe Ltd - Strategy, SWOT and Corporate Finance Report Summary Omaxe Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Ventana Medical Systems Inc-製薬・医療分野:企業M&A・提携分析
    Summary Ventana Medical Systems Inc (VMS), a subsidiary of F. Hoffmann-La Roche Ltd is a manufacturer of tissue-based diagnostic solutions for healthcare market. The company develops cancer diagnostic solutions for breast pathology, cervical diagnostics, colorectal pathology, special stains, lung pa …
  • AIA Group Limited:企業のM&A・事業提携・投資動向
    AIA Group Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's AIA Group Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • Prothena Corp Plc (PRTA)-医療機器分野:企業M&A・提携分析
    Summary Prothena Corp Plc (Prothena) is a biotechnology company that discovers, develops and markets novel antibodies that are indicated for the treatment of diseases associated with amyloid or cell adhesion. The company develops monoclonal antibodies directed specifically at disease-causing protein …
  • Siemens Healthineers AG (SHL):企業の財務・戦略的SWOT分析
    Siemens Healthineers AG (SHL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆